BenzingaSeptember 10, 2026 at 7:27 AM NYLast Month
BTIG Reiterates Buy on Serina Therapeutics, Maintains $8 Price Target
BTIG analyst Thomas Shrader reiterates Serina Therapeutics (AMEX:SER) with a Buy and maintains $8 price target.
Read the Full Story at the Source
The summary here comes from the news provider; the rest of the article lives on the publisher's site: Benzinga
